11 , eaal2171 (2018)
While that study did not report runaway tumor growth either, the lack of a spectacular reduction in tumor size, suggests BPC-157 offers no anti-cancer benefit and it leaves open the worry that it could even accelerate malignancy under the right conditions
Gary Gonzalez, MD, in October 2024
Patients with pre-existing subclinical nerve issues, perhaps from metabolic stress , vitamin deficiencies, or genetic predisposition, may respond differently to GLP-1 receptor activation than neurologically healthy patients
Best exercise to increase bone density 'GLP-1 medications can support weight loss, but they may also reduce muscle and bone mass,' says Rowan Clift, Freeletics PT and nutrition specialist
In line with evidence accrued in patients with T2D, incretin-based therapies produced a favorable effect on traditional cardiovascular risk factors, such as lipids and blood pressure, and even reduced the risk of major cardiovascular events and heart failure-related events in individuals with obesity, as recently demonstrated for the first time in the SELECT trial with semaglutide 2.4 mg once-weekly
